PE anti-human CD262 (DR5, TRAIL-R2) Antibody, CD262, A21121I,BioLegend,390706

Clone A21121I does not block the staining of reference clone DJR2-4 (7-8)Recombinant protein completely blocks the staining of test clone A21121I.

Host

Mouse

Reactivity

Human

Application

FC - Quality tested

Platform ID

BAB240984945

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NamePE anti-human CD262 (DR5, TRAIL-R2) Antibody, CD262, A21121I
Cat. No.390706
HostMouse
RRIDAB_3662287 (BioLegend Cat. No. 390705)AB_3662287 (BioLegend Cat. No. 390706)
IsotypeMouse IgG2a, κ
ReactivityHuman
ApplicationFC - Quality tested
ClonalityMonoclonal
Clone NumberA21121I
ConcentrationLot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in ourCertificate of Analysisonline tool.)
TargetCD262
ImmunogenRecombinant Human TNFRSF10B
PurityThe antibody was purified by affinity chromatography and conjugated with PE under optimal conditions.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
StorageThe antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light.Do not freeze.
Regulatory StatusResearch Use Only

Scientific Background

DR5, also known as TRAIL-R2, TRICK2, KILLER, and CD262, is 55 kD member 10B of the TNF receptor superfamily (TNFRSF10B). It binds the cytotoxic ligand, TRAIL, and induces apoptosis. The DR5 receptor is broadly expressed on a variety of normal tissues and many tumors. DR5 expression has been reported to be upregulated in human cells by interferon-α, 2-methoxyestradiol, and paclitaxel, and downregulated by adenoviral E3 proteins.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.